rosiglitazone has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barichello, T; Bogo, M; Burger, H; Constantino, L; Dal-Pizzol, F; de Quevedo, J; Dominguini, D; Gomes, LM; Kist, LW; Manfredini, A; Michels, M; Pinto, MC; Ritter, C; Silva, MC; Simioni, C; Singer, M; Steckert, A; Streck, E | 1 |
| Jia, JP; Liu, J; Wang, LN | 1 |
| Bai, Y; Fan, XM; Liang, QL; Luo, GA; Sun, H; Wang, YM | 1 |
1 review(s) available for rosiglitazone and Cognitive Decline
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis.
Topics: Alzheimer Disease; Cognitive Dysfunction; Humans; Hypoglycemic Agents; Pioglitazone; PPAR gamma; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2015 |
2 other study(ies) available for rosiglitazone and Cognitive Decline
| Article | Year |
|---|---|
Mitochondrial dysfunction is associated with long-term cognitive impairment in an animal sepsis model.
Topics: Animals; Autophagy; Brain; Cognitive Dysfunction; Disease Models, Animal; Male; Mitochondria; Mitochondrial Dynamics; Rats, Wistar; Rilmenidine; Rosiglitazone; Sepsis; Sirolimus; Survival Analysis; Up-Regulation | 2019 |
[The mechanism of rosiglitazone compound based on network pharmacology].
Topics: Calcium Signaling; Cognitive Dysfunction; Computational Biology; Diabetes Mellitus; Humans; Pharmacology; Rosiglitazone; Thiazolidinediones | 2015 |